Do your goods fall under the extension from exclusion on Section 301 duties for certain medical care imports from China? Find out here.
The onset of the COVID-19 pandemic created a “unique global trade environment” in 2020 and left a a profound impact on global economic activities and international trade, the U.S. International Trade said in its annual trade overview published this week.
With COVID-19 cases in the U.S. on the rise again due to spread of the Delta variant, the administration seeking public input on whether to extend by up to another 6 months, the Section 301 exclusions for 99 COVID-19 response “medical-care products” that are currently set to expire on September 30, 2021.
The FDA has revoked Emergency Use Authorizations for non-NIOSH-approved disposable respirators and the EUAs for decontamination and bioburden reduction systems. Find out if your goods are affected.
Trade ministers from the three countries gathered in Washington, D.C. this week to commemorate the one-year anniversary of the United States-Mexico-Canada Agreement’s coming into effect and to discuss its “achievements, challenges, and potential.”
With the notification to Congress, the U.S. became the third country to have completed its domestic legislative procedures needed to implement the deal, the final step necessary for the USMCA to take effect this summer. However, some are doubtful the three countries can achieve a comprehensive implementation in such a short time.